KEY PRODUCTS
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1Centrient Pharmaceuticals
01 1ATORVASTATIN CALCIUM
01 1Netherlands
01 1Active
01 1Complete
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
GDUFA
DMF Review : Complete
Rev. Date : 2016-05-31
Pay. Date : 2015-08-20
DMF Number : 29520
Submission : 2015-08-03
Status : Active
Type : II
20
Centrient Pharmaceuticals Netherlands Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
One of their notable products is ATORVASTATIN CALCIUM, with a corresponding US DMF Number 29520.
Remarkably, this DMF maintains an Active status since its submission on August 03, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 31, 2016, and payment made on August 20, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
